AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (420.9 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Current progress in cancer treatment by targeting FGFR signaling

Sicheng Du1, Ying Zhang1, Jianming Xu2 ( )
Department of Graduate Administration, Chinese People’s Liberation Army (PLA) General Hospital, Beijing 100853, China
Department of Oncology, The Fifth Medical Center of the PLA General Hospital, Beijing 100071, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 20 Issue 7,
July 2023
Pages 490-499
DOI: 10.20892/j.issn.2095-3941.2023.0137

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Du S, Zhang Y, Xu J. Current progress in cancer treatment by targeting FGFR signaling. Cancer Biology & Medicine, 2023, 20(7): 490-499. https://doi.org/10.20892/j.issn.2095-3941.2023.0137

534

Views

37

Downloads

59

Crossref

54

Web of Science

54

Scopus
Received: 20 April 2023
Accepted: 25 June 2023
Published: 01 July 2023
©2023 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License